Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

PaperCitations, authors & open-access status

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 246 citations, 2017 year and bronze oa status.

246
Citations
2017
Year
bronze
OA Status

Related on ScholarIQ

Silvio E. Inzucchi
Author
Christoph Wanner
Author
Jyothis T. George
Author
John M. Lachin
Author
Javed Butler
Author
Bernard Zinman
Author
470M+ articles · free account